Supernus Up on Report of Progress With ADHD Procedure

Supernus Pharmaceuticals  (SUPN) – Get Report shares jumped on Wednesday right after the drugmaker concentrated on the

Supernus Pharmaceuticals  (SUPN) – Get Report shares jumped on Wednesday right after the drugmaker concentrated on the central nervous process claimed progress in a Phase 3 research of an attention-deficit-hyperactivity-disorder drug.